Eikon reports Q3 2026 results, ESMO oncology data and new prostate cancer INDNov 12Quarterly updateAkari Therapeutics PlcAtrium Therapeutics
Akari Therapeutics reports Q2 2026 results, keeps AKTX-101 Phase 1 on track for mid-2027Aug 13Quarterly updateAkari Therapeutics Plc